- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc stock price live, this page displays NASDAQ COYA stock exchange data. View the COYA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Coya Therapeutics Inc real time stock price chart below.
What Is the Coya Therapeutics Inc Stock Price Today?
The Coya Therapeutics Inc stock price today is 4.58.
What Is the Stock Symbol for Coya Therapeutics Inc?
The stock symbol for Coya Therapeutics Inc is "COYA."
What Stock Exchange Does Coya Therapeutics Inc Trade On?
Coya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Coya Therapeutics Inc a Good Stock to Buy?
Determining whether Coya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COYA quote. (ISIN: US22407B1089)
What Is the Coya Therapeutics Inc Stock Price Today?
The Coya Therapeutics Inc stock price today is 4.58.
What Is the Stock Symbol for Coya Therapeutics Inc?
The stock symbol for Coya Therapeutics Inc is "COYA."
What Stock Exchange Does Coya Therapeutics Inc Trade On?
Coya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Coya Therapeutics Inc a Good Stock to Buy?
Determining whether Coya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COYA quote. (ISIN: US22407B1089)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.52
4.70
52 wk Range
3.71
7.75
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.524.70
52 wk Range
3.717.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COYA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
15.21
Upside
+232.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 8K Coya Therapeutics Inc For: 12 May- Investing.com
Coya Therapeutics receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Coya Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 424B5 Coya Therapeutics Inc For: 12 May
- Investing.com
Form 10Q Coya Therapeutics Inc For: 12 May- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.21
(+232.19% Upside)
Earnings
Latest Release
May 11, 2026
EPS / Forecast
-0.32 / -0.69
Revenue / Forecast
251.15M / --
Compare COYA to Peers and Sector
Metrics to compare | COYA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOYAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.1x | −6.4x | −0.4x | |
PEG Ratio | 0.72 | 0.12 | 0.00 | |
Price/Book | 2.2x | 4.5x | 2.6x | |
Price / LTM Sales | 13.5x | 23.4x | 3.0x | |
Upside (Analyst Target) | 240.7% | 62.5% | 50.7% | |
Fair Value Upside | Unlock | −5.2% | 7.2% | Unlock |
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer’s disease (AD), and Parkinson’s disease. In addition, its pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Coya Therapeutics (COYA) Stock Price Today?
The Coya Therapeutics stock price today is 4.58 USD.
What Stock Exchange Does Coya Therapeutics Trade On?
Coya Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Coya Therapeutics?
The stock symbol for Coya Therapeutics is "COYA."
What Is the Coya Therapeutics Market Cap?
As of today, Coya Therapeutics market cap is 107.43M USD.
What Is Coya Therapeutics's Earnings Per Share (TTM)?
The Coya Therapeutics EPS (TTM) is -1.16.
When Is the Next Coya Therapeutics Earnings Date?
Coya Therapeutics will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is COYA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Coya Therapeutics Stock Split?
Coya Therapeutics has split 0 times.
How Many Employees Does Coya Therapeutics Have?
Coya Therapeutics has 8 employees.
What is the current trading status of Coya Therapeutics (COYA)?
As of Aug 07, 2026, Coya Therapeutics (COYA) is trading at a price of 4.58 USD, with a previous close of 4.58 USD. The stock has fluctuated within a day range of 4.52 USD to 4.70 USD, while its 52-week range spans from 3.71 USD to 7.75 USD.
What Is Coya Therapeutics (COYA) Price Target According to Analysts?
The average 12-month price target for Coya Therapeutics is 15.21 USD, with a high estimate of 18 USD and a low estimate of 12 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +232.19% Upside potential.
What Is the COYA Premarket Price?
COYA's last pre-market stock price is 4.66 USD. The pre-market share volume is 1,470.00, and the stock has decreased by 0.11, or 2.42%.
What Is the COYA After Hours Price?
COYA's last after hours stock price is 4.88 USD, the stock has decreased by 0.30, or 6.48%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.